Australia's Memphasys at 8-month high on assessment results for medical device

Memphasys

03/11/2021 04:30

** Medical device maker's shares  MEM.AX  gain as much as
55% to A$0.09, highest since March 5
    ** Company says verification and validation assessments for
its "Felix" device, which extracts viable sperm from poor sperm
samples, is complete for early-access markets with low
regulatory requirements  urn:newsml:reuters.com:*:nGLF61FNSQ
    ** MEM says results from assessments positive and in line
with expectations
    ** Company continues to believe first commercial sale for
the device can be made prior to end of FY
    ** Stock on track for biggest intraday pct gain since May 26
    ** MEM eyes busiest trading day since May 26; around 7.8 mln
shares change hands, 22 times their 30-day moving average
    ** As of last close, company's shares down 40% so far this
year

 (Reporting by Roushni Nair in Bengluru)
 ((Roushni.Nair@thomsonreuters.com))